STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Apyx Medical (NASDAQ:APYX) announced that President and CEO Charles Goodwin and CFO Matt Hill will attend the 15th Annual Craig-Hallum Alpha Select Conference. The event will take place on November 19, 2024, at the Sheraton NY Times Square Hotel in New York, NY, featuring 1x1 meetings format.

Apyx Medical is an advanced energy technology company specializing in Helium Plasma Platform Technology products, marketed as Renuvion in cosmetic surgery and J-Plasma in hospital surgical markets. Their technology provides surgeons with controlled heat tissue treatment capabilities, supported by over 90 clinical documents.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conference:

Event: 15th Annual Craig-Hallum Alpha Select Conference
Date: November 19, 2024
Location: Sheraton NY Times Square Hotel, New York, NY
Format: 1x1 Meetings

To request a meeting with Apyx, investors should contact their Craig Hallum representative.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

Investor Relations Contact:

Jeremy Feffer, Managing Director LifeSci Advisors
OP: 212-915-2568
jfeffer@lifesciadvisors.com  


FAQ

When is Apyx Medical (APYX) attending the Craig-Hallum Alpha Select Conference in 2024?

Apyx Medical (APYX) will attend the Craig-Hallum Alpha Select Conference on November 19, 2024, at the Sheraton NY Times Square Hotel in New York.

What are the main products of Apyx Medical (APYX)?

Apyx Medical's main products are Renuvion for the cosmetic surgery market and J-Plasma for the hospital surgical market, both utilizing their Helium Plasma Platform Technology.

How many clinical documents support Apyx Medical's (APYX) Renuvion and J-Plasma products?

Apyx Medical's Renuvion and J-Plasma products are supported by more than 90 clinical documents.

Which Apyx Medical (APYX) executives will attend the 2024 Craig-Hallum Conference?

Charles Goodwin, President and CEO, and Matt Hill, CFO, will attend the Craig-Hallum Alpha Select Conference.
Apyx Medical Corporation

NASDAQ:APYX

APYX Rankings

APYX Latest News

APYX Latest SEC Filings

APYX Stock Data

164.06M
35.36M
14.55%
43.29%
0.61%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CLEARWATER